Authors: Novello, S Galli, L Antonuzzo, A Crino, L Pozzi, E Selvaggi, G Ricci, S Marrocolo, F Darwish, S Sorbolini, S Tonato, M Scagliotti, GV

Citation: S. Novello et al., Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer, LUNG CANC, 34(2), 2001, pp. 261-269

Authors: Dingemans, AMC van Ark-Otte, J Span, S Scagliotti, GV van der Valk, P Postmus, PE Giaccone, G

Citation: Amc. Dingemans et al., Topoisomerase II alpha and other drug resistance markers in advanced non-small cell lung cancer, LUNG CANC, 32(2), 2001, pp. 117-128

Authors: Rinaldi, M Crino, L Scagliotti, GV Mosconi, AM De Marinis, F Gridelli, C Selvaggi, G Della Giulia, M Darwish, S Porrozzi, S Novello, S Cipri, A Bartolucci, R Calandri, C Tonato, M

Citation: M. Rinaldi et al., A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: A phase II randomizedtrial, ANN ONCOL, 11(10), 2000, pp. 1295-1300

Authors: Scagliotti, GV Novello, S Selvaggi, G

Citation: Gv. Scagliotti et al., Multidrug resistance in non-small-cell lung cancer, ANN ONCOL, 10, 1999, pp. 83-86

Authors: Crino, L Scagliotti, GV Ricci, S De Marinis, F Rinaldi, M Gridelli, C Ceribelli, A Bianco, R Marangolo, M Di Costanzo, F Sassi, M Barni, S Ravaioli, A Adamo, V Portalone, L Cruciani, G Masotti, A Ferrara, G Gozzelino, F Tonato, M

Citation: L. Crino et al., Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian lung cancer project, J CL ONCOL, 17(11), 1999, pp. 3522-3530

Authors: Scagliotti, GV Crino, L Pozzi, E Corgna, E Selvaggi, G Novello, S Salsano, G Gentile, A Palladino, M Marracolo, F Tonato, M

Citation: Gv. Scagliotti et al., Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer, LUNG CANC, 25(1), 1999, pp. 39-46